Quetiapine dosage in bipolar disorder episodes and mixed states

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 3, 2007, Pages 727-730

  Khazaal, Yasser ^a   Tapparel, Sophie ^a   Chatton, Anne ^b   Rothen, Stephane ^a   Preisig, Martin ^a   Zullino, Daniele ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antipsychotic drugs; Bipolar disorder; Dosage; Quetiapine

Indexed keywords

ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; QUETIAPINE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; BECH-RAFAELSEN MANIA SCALE; BIPOLAR DISORDER; CLINICAL ARTICLE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD DISORDER; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SYMPTOM;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33947507790     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.01.006     Document Type: Article

References (14)

1. Bech P. The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure. CNS Drugs 16 (2002) 47-63
2. Bowden C.L., Grunze H., Mullen J., Brecher M., Paulsson B., Jones M., et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 66 (2005) 111-121
3. Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162 (2005) 1351-1360
4. Goldberg J.F., Garno J.L., Portera L., Leon A.C., and Kocsis J.H. Qualitative differences in manic symptoms during mixed versus pure mania. Compr Psychiatry 41 (2000) 237-241
5. Keller M.B., Lavori P.W., Coryell W., Andreasen N.C., Endicott J., Clayton P.J., et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255 (1986) 3138-3142
6. McIntyre R.S., Brecher M., Paulsson B., Huizar K., and Mullen J. Quetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 15 (2005) 573-585
7. Montgomery S., and Asberg A. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
8. Pierre J.M., Wirshing D.A., Wirshing W.C., Rivard J.M., Marks R., Mendenhall J., et al. High-dose quetiapine in treatment refractory schizophrenia. Schizophr Res 73 (2005) 373-375
9. Sachs G., Chengappa K.N., Suppes T., Mullen J.A., Brecher M., Devine N.A., et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. J Bipolar Disord 6 (2004) 213-223
10. Strakowski S.M., McElroy S.L., Keck Jr. P.E., and West S.A. Suicidality among patients with mixed and manic bipolar disorder. Am J Psychiatry 153 (1996) 674-676
11. Tondo L., Baldessarini R.J., Hennen J., Minnai G.P., Salis P., Scamonatti L., et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry 60 Suppl 2 (1999) 63-69
12. Vieta E. The treatment of mixed states and the risk of switching to depression. Eur Psychiatr 20 (2005) 96-100
13. Vieta E., Mullen J., Brecher M., Paulsson B., and Jones M. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr Med Res Opin 21 (2005) 923-934
14. Yatham L.N., Paulsson B., Mullen J., and Vagero A.M. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 24 (2004) 599-606